SCHEMBL1444907

SCHEMBL1444907

O=C(OCc1ccccc1)OC1CCC2CCC21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GAA P10253 1/20 0.42
CYP2C19 P33261 2/20 0.41
TSHR P16473 2/20 0.40
LMNA P02545 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21729626 0.85 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL17563242 0.77 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL17563460 0.77 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL17563241 0.77 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL11071047 0.74 TSHR (0.43) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL2900931 0.74 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL37382 0.73 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2MAPK1L3MBTL1SLC6A2
SCHEMBL11108392 0.72 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL1286990 0.72 KMT2A (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL10783810 0.72 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2477993-A1 SUBSTITUTED CLAVULANIC ACID Nabriva Therapeutics AG (AT) 2012-07-25 EP disclosed
WO-2011032192-A1 SUBSTITUTED CLAVULANIC ACID NABRIVA THERAPEUTICS AG (AT) 2011-03-24 WO disclosed